PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS)-A CANADIAN PERSPECTIVE
May 1, 2008, 00:00
10.1016/S1098-3015(10)70811-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)70811-1/fulltext
Title :
PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS)-A CANADIAN PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70811-1&doi=10.1016/S1098-3015(10)70811-1
First page :
Section Title :
Open access? :
No
Section Order :
561